Information  X 
Enter a valid email address

ONCIMMUNE (ONC)

Date Time Source Announcement
07 Dec 2021 7:00 am
RNS
Commercial momentum in ImmunoINSIGHTS
26 Nov 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  10:36 am
RNS
Results of Annual General Meeting
03 Nov 2021 7:00 am
RNS
Notice of AGM and posting of Annual Report
02 Nov 2021 7:00 am
RNS
Full year results and progress update
  7:00 am
RNS
Change of Adviser
27 Oct 2021 4:35 pm
RNS
Price Monitoring Extension
25 Oct 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Notice of Full Year results
20 Sep 2021 7:00 am
RNS
Agreement with pharma company to profile patients
15 Sep 2021 11:08 am
RNS
Block Listing Six Monthly Return
23 Aug 2021 7:00 am
RNS
Three-year follow-up data for the ECLS trial
23 Jul 2021 7:00 am
RNS
Agreement signed with major cancer center
22 Jul 2021 7:00 am
RNS
Validation of ImmunoINSIGHTS service in COVID-19
01 Jul 2021 7:00 am
RNS
Total Voting Rights
08 Jun 2021 7:00 am
RNS
Full Year Trading Update
28 May 2021 7:30 am
RNS
Notice of FY21 Trading Update
05 May 2021 7:03 am
RNS
Return of China Rights to EarlyCDT
04 May 2021 12:23 pm
RNS
Total Voting Rights
08 Apr 2021 7:00 am
RNS
Holding(s) in Company
07 Apr 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
06 Apr 2021 1:48 pm
RNS
Block Listing Six Monthly Return
  7:00 am
RNS
Agreements signed with Roche and Cedars-Sinai
  7:00 am
RNS
Holding(s) in Company
01 Apr 2021 7:00 am
RNS
Holding(s) in Company
25 Mar 2021 2:01 pm
RNS
Result of Oversubscribed Equity Placing
  7:45 am
RNS
Launch of Equity Placing via Accelerated Bookbuild
15 Mar 2021 7:00 am
RNS
Issue of Equity and Total Voting Rights
01 Mar 2021 7:00 am
RNS
Total Voting Rights
15 Feb 2021 7:00 am
RNS
Interim Results
25 Jan 2021 7:00 am
RNS
Notice of Half Year Results
19 Jan 2021 4:17 pm
RNS
Directorate Change
18 Jan 2021 11:37 am
RNS
Holding(s) in Company
14 Jan 2021 9:49 am
RNS
PDMR Dealing
06 Jan 2021 10:27 am
RNS
Total Voting Rights
18 Dec 2020 7:00 am
RNS
PDMR Dealing
15 Dec 2020 7:00 am
RNS
Autoantibody profiles publication for RA treatment
14 Dec 2020 7:00 am
RNS
EarlyCDT Lung blood test launch into the NHS
30 Nov 2020 11:21 am
RNS
Results of Annual General Meeting
11 Nov 2020 7:00 am
RNS
Agreement with Augmenta Bioworks
09 Nov 2020 7:00 am
RNS
Notice of AGM and Posting of Annual Report
30 Oct 2020 7:00 am
RNS
Full year results and progress update
28 Oct 2020 7:00 am
RNS
Clinical study initiated by Biodesix in US
21 Oct 2020 7:00 am
RNS
Abstracts of Studies using EarlyCDT Lung
19 Oct 2020 8:21 am
RNS
Replacement: Notice of Full Year Results
13 Oct 2020 7:00 am
RNS
Agreement with Cedars-Sinai to Profile COVID-19
08 Oct 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
06 Oct 2020 7:00 am
RNS
UK Government funding for tool for use in COVID-19
23 Sep 2020 7:00 am
RNS
Profiling samples from Genentech
15 Sep 2020 2:00 pm
RNS
Block Admission
11 Sep 2020 12:14 pm
RNS
New Incentivisation Scheme for Senior Management
03 Sep 2020 7:00 am
RNS
Cost-effectiveness study assessing EarlyCDT Lung
02 Sep 2020 7:00 am
RNS
Autoantibody profiling agreement signed
13 Aug 2020 11:38 am
RNS
Exercise of Options and Total Voting Rights
12 Aug 2020 7:00 am
RNS
Appointment of Joint Brokers
10 Aug 2020 7:00 am
RNS
EarlyCDT Lung Blood Test Featured on ITV News

a d v e r t i s e m e n t